Sold Momenta Pharmaceuticals
I don’t like the tape action here and it looks a bit tired so I’m raising some cash. I took some quick profits in Momenta Pharmaceuticals (Ticker: MNTA) at $15.49 generating a 3.26% gain over a two day period. Everyone is hoping that Momenta Pharmaceutical remains the only Lovenex generic player, but that is doubtful. Teva Pharmaceuticals (Ticker: TEVA) is expected to receive approval at any moment. This will lower the profit sharing agreement between Momenta Pharmaceuticals and Sandoz. Right now, Momenta Pharmaceuticals is in a sweet spot, but I don’t think it will last much longer.
posted by Money Turtle @ 1:46 PM
2 comments
2 Comments:
You failed to do your homework.
TEVA said they were getting approval several months ago. What happened??
TEVA's generic LOVENOX is being manufactured & distributed by a 3rd party. The FDA will not approve their generic since the FDA has established a 5 point criteria. TEVA doesn't have the technical skill that MNTA has (via patents).
MNTA 3Q earnings will be out Nov. 1. Most analysts predict .68+
Thanks for the feed back. I know I'm lazy sometimes and don't do my homework completely. I may get back in Momenta...
Post a Comment
<< Home